Supernus Pharmaceuticals | DEBITO



Debt Cambiamento Data
Abbott USD 14.98B 225M 2024-09
ANI Pharmaceuticals USD 624.09M 304.02M 2024-12
Aurora Cannabis CAD 100.98M 11K 2024-12
Bristol-Myers Squibb USD 49.65B 103M 2024-12
Canopy Growth CAD 489.67M 123.85M 2024-12
Corcept Therapeutics USD 0 0 2024-12
Eisai JPY 219.1B 36.2B 2024-12
Eli Lilly USD 33.64B 2.52B 2024-12
Indivior 284M 3M 2024-09
Novo Nordisk 56.97B 88M 2024-09
Pacira USD 585.32M 2.04M 2024-12
Perrigo USD 3.62B 1.14B 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12
United Therapeutics USD 300M 100M 2024-12
Xeris Pharmaceuticals USD 247.21M 15.93M 2024-12



Supernus Pharmaceuticals DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.